Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women With Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
NCT02311933Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- May 2015
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
A Phase 2 trial of z-endoxifen in breast cancer, sponsored by National Cancer Institute. Started May 2015; status: active, not recruiting.
02
Drugs
z-endoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02311933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311933.